These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 25883023)
1. INPP4B Is a PtdIns(3,4,5)P3 Phosphatase That Can Act as a Tumor Suppressor. Kofuji S; Kimura H; Nakanishi H; Nanjo H; Takasuga S; Liu H; Eguchi S; Nakamura R; Itoh R; Ueno N; Asanuma K; Huang M; Koizumi A; Habuchi T; Yamazaki M; Suzuki A; Sasaki J; Sasaki T Cancer Discov; 2015 Jul; 5(7):730-9. PubMed ID: 25883023 [TBL] [Abstract][Full Text] [Related]
2. The INPP4B paradox: Like PTEN, but different. Hamila SA; Ooms LM; Rodgers SJ; Mitchell CA Adv Biol Regul; 2021 Dec; 82():100817. PubMed ID: 34216856 [TBL] [Abstract][Full Text] [Related]
3. INPP4B Is a Tumor Suppressor in the Context of PTEN Deficiency. Vo TT; Fruman DA Cancer Discov; 2015 Jul; 5(7):697-700. PubMed ID: 26152921 [TBL] [Abstract][Full Text] [Related]
4. In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at Endosomes. Li Chew C; Lunardi A; Gulluni F; Ruan DT; Chen M; Salmena L; Nishino M; Papa A; Ng C; Fung J; Clohessy JG; Sasaki J; Sasaki T; Bronson RT; Hirsch E; Pandolfi PP Cancer Discov; 2015 Jul; 5(7):740-51. PubMed ID: 25883022 [TBL] [Abstract][Full Text] [Related]
5. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. Maehama T; Dixon JE J Biol Chem; 1998 May; 273(22):13375-8. PubMed ID: 9593664 [TBL] [Abstract][Full Text] [Related]
6. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases. Rodgers SJ; Ferguson DT; Mitchell CA; Ooms LM Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28082369 [TBL] [Abstract][Full Text] [Related]
7. PTEN and Other PtdIns(3,4,5)P Csolle MP; Ooms LM; Papa A; Mitchell CA Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276499 [TBL] [Abstract][Full Text] [Related]
8. PTEN: life as a tumor suppressor. Simpson L; Parsons R Exp Cell Res; 2001 Mar; 264(1):29-41. PubMed ID: 11237521 [TBL] [Abstract][Full Text] [Related]
9. INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC. Reed DE; Shokat KM Mol Cancer Res; 2017 Jun; 15(6):765-775. PubMed ID: 28196852 [TBL] [Abstract][Full Text] [Related]
10. Determinants of the tumor suppressor INPP4B protein and lipid phosphatase activities. Lopez SM; Hodgson MC; Packianathan C; Bingol-Ozakpinar O; Uras F; Rosen BP; Agoulnik IU Biochem Biophys Res Commun; 2013 Oct; 440(2):277-82. PubMed ID: 24070612 [TBL] [Abstract][Full Text] [Related]
12. Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers. Fedele CG; Ooms LM; Ho M; Vieusseux J; O'Toole SA; Millar EK; Lopez-Knowles E; Sriratana A; Gurung R; Baglietto L; Giles GG; Bailey CG; Rasko JE; Shields BJ; Price JT; Majerus PW; Sutherland RL; Tiganis T; McLean CA; Mitchell CA Proc Natl Acad Sci U S A; 2010 Dec; 107(51):22231-6. PubMed ID: 21127264 [TBL] [Abstract][Full Text] [Related]
13. Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer. Hodgson MC; Shao LJ; Frolov A; Li R; Peterson LE; Ayala G; Ittmann MM; Weigel NL; Agoulnik IU Cancer Res; 2011 Jan; 71(2):572-82. PubMed ID: 21224358 [TBL] [Abstract][Full Text] [Related]
14. Phosphoinositide phosphatases: just as important as the kinases. Dyson JM; Fedele CG; Davies EM; Becanovic J; Mitchell CA Subcell Biochem; 2012; 58():215-79. PubMed ID: 22403078 [TBL] [Abstract][Full Text] [Related]
15. Deletion of inositol polyphosphate 4-phosphatase type-II B affects spermatogenesis in mice. Ceyhan Y; Zhang M; Guo J; Sandoval CG; Vacher J; Kaftanovskaya EM; Agoulnik AI; Agoulnik IU PLoS One; 2020; 15(5):e0233163. PubMed ID: 32413098 [TBL] [Abstract][Full Text] [Related]
16. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1. Bruni P; Boccia A; Baldassarre G; Trapasso F; Santoro M; Chiappetta G; Fusco A; Viglietto G Oncogene; 2000 Jun; 19(28):3146-55. PubMed ID: 10918569 [TBL] [Abstract][Full Text] [Related]
17. Regulation of PtdIns(3,4,5)P3/Akt signalling by inositol polyphosphate 5-phosphatases. Eramo MJ; Mitchell CA Biochem Soc Trans; 2016 Feb; 44(1):240-52. PubMed ID: 26862211 [TBL] [Abstract][Full Text] [Related]
18. Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1. Nishio M; Watanabe K; Sasaki J; Taya C; Takasuga S; Iizuka R; Balla T; Yamazaki M; Watanabe H; Itoh R; Kuroda S; Horie Y; Förster I; Mak TW; Yonekawa H; Penninger JM; Kanaho Y; Suzuki A; Sasaki T Nat Cell Biol; 2007 Jan; 9(1):36-44. PubMed ID: 17173042 [TBL] [Abstract][Full Text] [Related]
19. The complexity of PTEN: mutation, marker and potential target for therapeutic intervention. Steelman LS; Bertrand FE; McCubrey JA Expert Opin Ther Targets; 2004 Dec; 8(6):537-50. PubMed ID: 15584861 [TBL] [Abstract][Full Text] [Related]